Masumi Ueda

2.1k total citations · 1 hit paper
87 papers, 1.2k citations indexed

About

Masumi Ueda is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Masumi Ueda has authored 87 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 21 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Masumi Ueda's work include Hematopoietic Stem Cell Transplantation (17 papers), Acute Myeloid Leukemia Research (11 papers) and Cytomegalovirus and herpesvirus research (8 papers). Masumi Ueda is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Acute Myeloid Leukemia Research (11 papers) and Cytomegalovirus and herpesvirus research (8 papers). Masumi Ueda collaborates with scholars based in United States, Japan and South Africa. Masumi Ueda's co-authors include Steven A. Pergam, Catherine Liu, F. Marc Stewart, Jennie R. Crews, David R. Byrd, Tracy Wong, Barbara Jagels, Renato Martins, Paul C. Hendrie and Nancy E. Davidson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Masumi Ueda

76 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal

2020 367 citations Masumi Ueda, Steven A. Pergam et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masumi Ueda United States	17	442	292	144	139	133	87	1.2k
Steven Hirschfeld United States	23	338 0.8×	802 2.7×	74 0.5×	149 1.1×	142 1.1×	72	2.1k
Julie Wu United States	16	237 0.5×	198 0.7×	92 0.6×	51 0.4×	88 0.7×	51	1.3k
Chunling Wang China	17	164 0.4×	362 1.2×	75 0.5×	96 0.7×	79 0.6×	91	1.2k
Henry W. Lim United States	19	209 0.5×	290 1.0×	66 0.5×	228 1.6×	184 1.4×	34	3.0k
Mark R. Wakefield United States	21	488 1.1×	311 1.1×	73 0.5×	27 0.2×	114 0.9×	109	1.7k
Yong Wu China	18	209 0.5×	315 1.1×	102 0.7×	92 0.7×	75 0.6×	78	1.2k
Carlos Medina Ireland	21	421 1.0×	494 1.7×	43 0.3×	161 1.2×	340 2.6×	30	1.7k
J.M. Carrascosa Spain	30	154 0.3×	227 0.8×	188 1.3×	180 1.3×	317 2.4×	211	3.0k
Jeffrey L. Berenberg United States	19	829 1.9×	191 0.7×	34 0.2×	112 0.8×	103 0.8×	63	1.7k
Sue Li United States	14	222 0.5×	194 0.7×	128 0.9×	54 0.4×	160 1.2×	26	1.3k

Countries citing papers authored by Masumi Ueda

Since Specialization

Citations

This map shows the geographic impact of Masumi Ueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masumi Ueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masumi Ueda more than expected).

Fields of papers citing papers by Masumi Ueda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masumi Ueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masumi Ueda. The network helps show where Masumi Ueda may publish in the future.

Co-authorship network of co-authors of Masumi Ueda

This figure shows the co-authorship network connecting the top 25 collaborators of Masumi Ueda. A scholar is included among the top collaborators of Masumi Ueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masumi Ueda. Masumi Ueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sadowska‐Klasa, Alicja, Hu Xie, Danniel Zamora, et al.. (2025). Cytomegalovirus Viral Load Continues to Predict Poor Outcomes in Adults and Children Despite Improved Hematopoietic Cell Transplantation Success. Open Forum Infectious Diseases. 12(11). ofaf612–ofaf612. 1 indexed citations

Ueda, Masumi, Michael Boeckh, M Bouvier, et al.. (2025). Sirolimus and Cyclosporine With Post-Transplant Cyclophosphamide or Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis in Unrelated Donor Hematopoietic Cell Transplantation. Journal of Clinical Oncology. 43(33). 3600–3609.

Rosen, Emily A., Elizabeth M. Krantz, Denise J. McCulloch, et al.. (2024). COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 Therapeutics. Transplantation and Cellular Therapy. 30(11). 1108.e1–1108.e11. 2 indexed citations

Woost, Philip G., Basem M. William, Brenda Cooper, et al.. (2024). Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies. Cytometry Part B Clinical Cytometry. 106(1). 11–24.

Carpenter, Paul A., Theodore A. Gooley, Catherine J. Lee, et al.. (2024). Decreasing chronic graft-versus-host disease rates in all populations. Blood Advances. 8(22). 5829–5837. 6 indexed citations

Banerjee, Rahul, Andrew J. Cowan, Paul A. Carpenter, et al.. (2024). Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 24(7). 446–454.e3. 16 indexed citations

Ueda, Masumi, Hu Xie, Danniel Zamora, et al.. (2023). Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation. Blood Advances. 7(8). 1394–1403. 12 indexed citations

Kampouri, Eleftheria, Danniel Zamora, Louise E. Kimball, et al.. (2023). Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis. Clinical Microbiology and Infection. 29(11). 1450.e1–1450.e7. 9 indexed citations

Ueda, Masumi, et al.. (2023). Analysis of health care facility-onset Clostridioides difficile infection (CDI) in a hematopoietic cell transplant (HCT) unit: A call for diagnostic stewardship in a complex patient population. American Journal of Infection Control. 52(3). 374–376. 2 indexed citations

10.

Ullrich, Christina, Kelsey K. Baker, Paul A. Carpenter, et al.. (2022). Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies. Transplantation and Cellular Therapy. 29(3). 200.e1–200.e8. 8 indexed citations

11.

Krakow, Elizabeth F., Albert C. Yeh, Masumi Ueda, et al.. (2022). Late Effects of Severe Acute Graft-versus-Host Disease on Quality of Life, Medical Comorbidities, and Survival. Transplantation and Cellular Therapy. 28(12). 844.e1–844.e8. 3 indexed citations

12.

Wang, Rong, Xuyang Li, Tomonari Muramatsu, et al.. (2020). Improved preparation of group-specific component (Gc) protein to derive macrophage activating factor. Protein Expression and Purification. 175. 105714–105714. 1 indexed citations

13.

Ueda, Masumi, Brenda M. Sandmaier, Effie W. Petersdorf, et al.. (2020). Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach. Bone Marrow Transplantation. 56(2). 305–313. 6 indexed citations

14.

Ueda, Masumi, Barry E. Storer, Huiying Qiu, et al.. (2020). Long-term Outcomes with Nonmyeloablative HLA-Identical Related Hematopoietic Cell Transplantation Using Tacrolimus and Mycophenolate Mofetil for Graft-versus-Host Disease Prophylaxis. Transplantation and Cellular Therapy. 27(2). 163.e1–163.e7.

15.

Adachi, Yoshiko, et al.. (2018). [The relationship between sleep and subjective mental health at one month postpartum in Japanese women].. PubMed. 65(11). 646–654. 4 indexed citations

16.

Ueda, Masumi, Brenda Cooper, Paolo F. Caimi, et al.. (2018). Low-Dose Azacitidine with DNMT1 Level Monitoring to Treat Post-Transplantation Acute Myelogenous Leukemia or Myelodysplastic Syndrome Relapse. Biology of Blood and Marrow Transplantation. 25(6). 1122–1127. 9 indexed citations

17.

Ueda, Masumi, et al.. (2017). Late recurrence of autologous GvHD in a myeloma patient: a myth or diagnostic challenge?. Bone Marrow Transplantation. 52(6). 910–912. 3 indexed citations

18.

Hu, Sophia, Masumi Ueda, Lindsay Stetson, et al.. (2016). A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity. Molecular Cancer Therapeutics. 15(7). 1485–1494. 35 indexed citations

19.

Ueda, Masumi. (1969). Subcellular Distribution of Electron Transport Systems in Candida albicans and Candida tropicalis. Nippon Saikingaku Zasshi. 24(7). 317–324. 2 indexed citations

20.

Takagi, Atsushi, et al.. (1967). The Significance of Membrane Component and Ribosomes in Immunization with the Particulate Fraction from Salmonella enteritidis Cells. Nippon Saikingaku Zasshi. 22(2). 61–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact